Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126250563 | 12625056 | 3 | F | 201410 | 20160913 | 20160805 | 20160916 | PER | US-PFIZER INC-2016362785 | PFIZER | 77.00 | YR | F | Y | 70.31000 | KG | 20160916 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126250563 | 12625056 | 1 | PS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, DAILY | N | 20998 | 200 | MG | CAPSULE, HARD | ||||||
| 126250563 | 12625056 | 2 | SS | CELEBREX | CELECOXIB | 1 | 200 MG, DAILY | N | 20998 | 200 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126250563 | 12625056 | 1 | Occipital neuralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126250563 | 12625056 | Back pain | |
| 126250563 | 12625056 | Intervertebral disc protrusion | |
| 126250563 | 12625056 | Neuralgia | |
| 126250563 | 12625056 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126250563 | 12625056 | 1 | 201408 | 201410 | 0 |